KRYS
Krystal Biotech Inc
334.90$
+3.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.7% | 71.8% | 70.6% | 74.4% | 72.6% | 70.3% | 71.4% | 73.9% | 74.6% | 76.8% | 73.0% | 70.6% | |
| 47.2% | 43.8% | 42.1% | 37.7% | 38.1% | 32.7% | 28.7% | 31.1% | 31.7% | 37.2% | 35.9% | 28.5% | |
| 71.1% | 65.0% | 63.1% | 61.0% | 59.9% | 56.6% | 57.4% | 59.9% | 59.0% | 62.1% | 58.9% | 56.4% | |
| 1.2% | 5.1% | 5.4% | 11.2% | 9.9% | 9.9% | 9.6% | 9.8% | 10.5% | 9.6% | 9.1% | 9.2% | |
| 0.7% | 0.9% | 1.3% | 1.3% | 1.9% | 2.5% | 2.8% | 2.7% | 3.0% | 3.0% | 3.1% | 3.0% | |
| 4.4% | 4.9% | 6.3% | 8.6% | 9.8% | 10.4% | 8.4% | 8.6% | 8.2% | 8.6% | 8.6% | 9.4% | |
| 3.5% | 4.0% | 5.6% | 7.8% | 9.1% | 9.7% | 7.4% | 7.6% | 7.4% | 7.7% | 7.7% | 8.5% | |
| 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 0.5% | 0.5% | 0.6% | 0.6% | 0.6% | 0.5% | 0.2% | 0.6% | 0.2% | 0.2% | 0.3% | 0.4% | |
| 95.6% | 95.1% | 93.7% | 91.4% | 90.2% | 89.6% | 91.6% | 91.4% | 91.8% | 91.4% | 91.4% | 90.6% | |
| -35.2% | -33.0% | -31.5% | -27.6% | -23.0% | -17.1% | -13.5% | -9.4% | -2.2% | 1.8% | 5.7% | 9.0% | |
| 3.7% | 3.5% | 3.4% | 3.2% | 3.0% | 2.8% | 2.8% | 2.6% | 2.4% | 2.2% | 2.2% | 2.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.